These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8073289)

  • 1. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco.
    Blower SM; McLean AR
    Science; 1994 Sep; 265(5177):1451-4. PubMed ID: 8073289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tale of two futures: HIV and antiretroviral therapy in San Francisco.
    Blower SM; Gershengorn HB; Grant RM
    Science; 2000 Jan; 287(5453):650-4. PubMed ID: 10649998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS: modeling epidemic control.
    Longini IM; Halloran ME
    Science; 1995 Mar; 267(5202):1250-1; author reply 1252-3. PubMed ID: 7871414
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS: modeling epidemic control.
    Rida W; Fast P; Hoff R; Barker L
    Science; 1995 Mar; 267(5202):1251-2; author reply 1252-3. PubMed ID: 7871415
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in the San Francisco Human Immunodeficiency Virus Epidemic in the "Getting to Zero" Era.
    Scheer S; Hsu L; Schwarcz S; Pipkin S; Havlir D; Buchbinder S; Hessol NA
    Clin Infect Dis; 2018 Mar; 66(7):1027-1034. PubMed ID: 29099913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based optimization of infectivity parameters: a study of the early epidemic in San Francisco.
    Ahlgren DJ; Gorny MK; Stein AC
    J Acquir Immune Defic Syndr (1988); 1990; 3(6):631-43. PubMed ID: 2338619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco.
    Spindler HH; Scheer S; Chen SY; Klausner JD; Katz MH; Valleroy LA; Schwarcz SK
    Sex Transm Dis; 2007 Aug; 34(8):586-91. PubMed ID: 17334264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in prevalence of HIV infection and sexual risk behavior in men who have sex with men in San Francisco: 1997 2002.
    Osmond DH; Pollack LM; Paul JP; Catania JA
    Am J Public Health; 2007 Sep; 97(9):1677-83. PubMed ID: 17463390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical Models.
    Dimitrov D; Kublin JG; Ramsey S; Corey L
    EBioMedicine; 2015 Dec; 2(12):2062-9. PubMed ID: 26844286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. San Francisco officials discuss higher HIV prevalence among black MSM.
    AIDS Patient Care STDS; 2008 Feb; 22(2):165. PubMed ID: 18273943
    [No Abstract]   [Full Text] [Related]  

  • 11. Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men. The San Francisco/Berkeley Young Men's Survey.
    Lemp GF; Hirozawa AM; Givertz D; Nieri GN; Anderson L; Lindegren ML; Janssen RS; Katz M
    JAMA; 1994 Aug; 272(6):449-54. PubMed ID: 8040980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for AIDS in multiethnic neighborhoods in San Francisco, California. The population-based AMEN Study.
    Fullilove MT; Wiley J; Fullilove RE; Golden E; Catania J; Peterson J; Garrett K; Siegel D; Marin B; Kegeles S
    West J Med; 1992 Jul; 157(1):32-40. PubMed ID: 1413740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expected epidemiological impacts of introducing an HIV vaccine in Thailand: a model-based analysis.
    Schneider K; Kerr CC; Hoare A; Wilson DP
    Vaccine; 2011 Aug; 29(36):6086-91. PubMed ID: 21723902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choices, beliefs, and infectious disease dynamics.
    Auld MC
    J Health Econ; 2003 May; 22(3):361-77. PubMed ID: 12683957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of human immunodeficiency virus type 1 infection among homosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990.
    van Griensven GJ; Hessol NA; Koblin BA; Byers RH; O'Malley PM; Albercht-van Lent N; Buchbinder SP; Taylor PE; Stevens CE; Coutinho RA
    Am J Epidemiol; 1993 Apr; 137(8):909-15. PubMed ID: 8484382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of a factual model for the dynamics of the transmission of infection by the human immunodeficiency virus: an example for animal epidemiology].
    Le Pont F; Valleron AJ
    Rev Sci Tech; 1993 Mar; 12(1):73-82. PubMed ID: 8518448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation and National Dissemination of a Brief, Evidence-Based, HIV Prevention Intervention for High-Risk Men Who Have Sex with Men.
    Herbst JH; Raiford JL; Carry MG; Wilkes AL; Ellington RD; Whittier DK
    MMWR Suppl; 2016 Feb; 65(1):42-50. PubMed ID: 26916033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics.
    Owens DK; Edwards DM; Shachter RD
    AIDS; 1998 Jun; 12(9):1057-66. PubMed ID: 9662203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
    Blower S; Schwartz EJ; Mills J
    AIDS Rev; 2003; 5(2):113-25. PubMed ID: 12876900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.